The antioxidant paradox in diabetes mellitus

American Journal of Therapeutics

Volumn 18, Issue 3, 2011, Pages 266-278

  Sheikh Ali, Mae ^a   Chehade, Joe M ^a   Mooradian, Arshag D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

antioxidants; cardiovascular disease; diabetes mellitus; oxidative stress

Indexed keywords

ACETYLSALICYLIC ACID; ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; ASCORBIC ACID; BETA CAROTENE; CYANOCOBALAMIN; FOLIC ACID; FREE RADICAL; GLUCOSE; MOLYBDENUM; NICOTINIC ACID; PYRIDOXINE; REACTIVE OXYGEN METABOLITE; RETINOL; RIBOFLAVIN; SELENIUM; TRACE ELEMENT; ZINC;

ANTIOXIDANT ACTIVITY; ARTICLE; AUTOOXIDATION; CARDIOVASCULAR DISEASE; CLINICAL STUDY; DIABETES MELLITUS; DIETARY INTAKE; DRUG TREATMENT FAILURE; EPIDEMIOLOGY; FOOD INTAKE; HEALTH SURVEY; HUMAN; INTERVENTION STUDY; LOW DRUG DOSE; MITOCHONDRIAL RESPIRATION; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; STOMACH CANCER; TREATMENT OUTCOME; VITAMIN INTAKE;

ANTIOXIDANTS; DIABETES MELLITUS; FEMALE; FREE RADICALS; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MICRONUTRIENTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 79958032104     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181b7badf     Document Type: Article

References (80)

1. Mooradian AD. Antioxidants and diabetes. Antioxidants and diabetes. Nestle Nutr Workshop Ser Clin Perform Prog. 2006;11:107-122.
2. Hasanain B, Mooradian AD. Antioxidant vitamins and their influence in diabetes mellitus. Curr Diab Rep. 2002;2: 448-456.
3. Mooradian AD. Cardiovascular disease in type 2 diabetes mellitus: current management guidelines. Arch Intern Med. 2003;163:33-40. (Pubitemid 36091598)
4. Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842-857. (Pubitemid 46333949)
5. Kaneto H, Kawamori D, Matsuoka TA, et al. Oxidative stress and pancreatic beta-cell dysfunction. Am J Ther. 2005;12:529-533. (Pubitemid 41689753)
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414:813-820 (Pubitemid 34000785)
7. Davi G, Falco A, Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal 2005;7:256-268. (Pubitemid 40187942)
8. Evans JL, Goldfine ID, Maddux BA, et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23: 599-622. (Pubitemid 35191625)
9. Rosen P, Nawroth PP, King G, et al. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev. 2001;17:189-212. (Pubitemid 32624602)
10. Maritim AC, Sanders RA, Watkins JB, 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24-38. (Pubitemid 36410972)
11. Martin-Gallan P, Carrascosa A, Gussinye M, et al. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med. 2003;34: 1563-1574. (Pubitemid 36638716)
12. Oberley LW. Free radicals and diabetes. Free Radic Biol Med. 1988;5:113-124. (Pubitemid 18263730)
13. Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal. 2005;7:1040-1052. (Pubitemid 40967154)
14. Sharma A, Kharb S, Chugh SN, et al. Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism. 2000;49:160-162. (Pubitemid 30090877)
15. Horani MH, Haas MJ, Mooradian AD. Rapid adaptive down regulation of oxidative burst induced by high dextrose in human umbilical vein endothelial cells. Diabetes Res Clin Pract. 2004;66:7-12. (Pubitemid 39201366)
16. Ceriello A. The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia. 2003;46(Suppl 1):M9-M16. (Pubitemid 36543098)
17. Zhang C, Yang J, Jennings LK. Leukocyte-derived myeloperoxidase amplifies high-glucose-induced endothelial dysfunction through interaction with high-glucosestimulated, vascular non-leukocyte-derived reactive oxygen species. Diabetes. 2004;53:2950-2959. (Pubitemid 39425921)
18. Boudjeltia KZ, Legssyer I, Van Antwerpen P, et al. Triggering of inflammatory response by myeloperoxidase- oxidized LDL. Biochem Cell Biol. 2006;84:805-812. (Pubitemid 46121606)
19. Mocatta TJ, Pilbrow AP, Cameron VA, et al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol. 2007;49: 1993-2000. (Pubitemid 46734639)
20. Boker T, Augustin AJ, Breipohl W, et al. Increased lipid peroxide level and myeloperoxidase activity in the vitreous of patients suffering from proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 1994;232: 652-656. (Pubitemid 24313568)
21. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med. 2000;29:222-230.
22. Toborek M, Hennig B. Fatty acid-mediated effects on the glutathione redox cycle in cultured endothelial cells. Am J Clin Nutr. 1994;59:60-65. (Pubitemid 24021709)
23. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med. 1995;46:223-234.
24. Bierhaus A, Hofmann MA, Ziegler R, et al. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res. 1998;37:586-600. (Pubitemid 28231153)
25. Wehmeier KR, Mooradian AD. Autoxidative and antioxidative potential of simple carbohydrates. Free Radic Biol Med. 1994;17:83-86. (Pubitemid 24212714)
26. Wolff SP, Dean RT. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J. 1987;245:243-250. (Pubitemid 17089839)
27. Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J. 1988; 256:205-212.
28. Maxwell SR, Thomason H, Sandler D, et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest. 1997;27:484-490. (Pubitemid 27288358)
29. Godin DV, Wohaieb SA, Garnett ME, et al. Antioxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem. 1988;84:223-231. (Pubitemid 19027111)
30. Mooradian AD. The antioxidative potential of cerebral microvessels in experimental diabetes mellitus. Brain Res. 1995;671:164-169.
31. Uchimura K, Nagasaka A, Hayashi R, et al. Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus. J Diabetes Complications. 1999;13: 264-270. (Pubitemid 30182606)
32. Opara EC, Abdel-Rahman E, Soliman S, et al. Depletion of total antioxidant capacity in type 2 diabetes. Metabolism. 1999;48:1414-1417. (Pubitemid 29536441)
33. Karabina SA, Lehner AN, Frank E, et al. Oxidative inactivation of paraoxonase-implications in diabetes mellitus and atherosclerosis. Biochim Biophys Acta. 2005; 1725:213-221. (Pubitemid 41253931)
34. van den Berg SW, Jansen EH, Kruijshoop M, et al. Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study). Diabet Med. 2008;25:186-193. (Pubitemid 351293397)
35. Chiu KC, Chuang LM, Chu A, et al. Association of paraoxonase 1 polymorphism with beta-cell function: a case of molecular heterosis. Pancreas. 2004;28:e96-e103.
36. Kinumi T, Ogawa Y, Kimata J, et al. Proteomic characterization of oxidative dysfunction in human umbilical vein endothelial cells (HUVEC) induced by exposure to oxidized LDL. Free Radic Res. 2005;39: 1335-1344. (Pubitemid 43023798)
37. Kopprasch S, Pietzsch J, Kuhlisch E, et al. Lack of association between serum paraoxonase 1 activities and increased oxidized low-density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus. J Clin Endocrinol Metab. 2003;88:1711-1716. (Pubitemid 36623393)
38. Kalousová M, Zima T, Tesar V, et al. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res. 2005;579:37-46. (Pubitemid 41540131)
39. Paz K, Hemi R, LeRoith D, et al. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem. 1997;272:29911-29918.
40. Qiao LY, Goldberg JL, Russell JC, et al. Identification of enhanced serine kinase activity in insulin resistance. J Biol Chem. 1999;274:10625-10632.
41. Laybutt DR, Kaneto H, Hasenkamp W, et al. Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to beta-cell survival during chronic hyperglycemia. Diabetes. 2002;51:413-423. (Pubitemid 34764797)
42. Weir GC, Laybutt DR, Kaneto H, et al. A. Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes. 2001;50(Suppl 1):S154-S159. (Pubitemid 32148243)
43. Cardozo AK, Heimberg H, Heremans Y, et al. A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J Biol Chem. 2001;276:48879-48886.
44. Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl. 2000;77:S113-S119.
45. Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia. 2000;43:1205-1223.
46. Kushi LH, Folsom AR, Prineas RJ, et al. Dietary antioxidant vitamins and death from coronary in postmenopausal women. N Eng J Med. 1996;334:1156-1162. (Pubitemid 26137974)
47. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449. (Pubitemid 23143846)
48. Yochum LA, Folsom AR, Kushi LH. Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr. 2000;72:476-483. (Pubitemid 30620655)
49. Klipstein-Grobusch K, Geleijnse JM, den Bleeijen JH, et al: Dietary antioxidants and risk of myocardial infarction in the elderly. The Rotterdam Study. Am J Clin Nutr. 1999;69: 261-266. (Pubitemid 29065549)
50. Losonczy KG, Harris TB, Havlik RS. Vitamin E and vitamin C supplement use and risk of all cause and coronary heart disease mortality in older persons: the Established Population for Epidemiologic Studies of the Elderly. Am J Clin Nutr. 1996;64:190-196. (Pubitemid 26250838)
51. Knekt P, Reunanen A, Jarvinen R, et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol. 1994;139:1180-1189. (Pubitemid 24184411)
52. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456. (Pubitemid 23143847)
53. Todd S, Woodward M, Tunstall-Pedoe H, et al. Dietary antioxidant vitamins and fiber in the etiology of cardiovascular disease and all-cause mortality: Results from the Scottish hear health study. Am J Epidemiol. 1999;150: 1073-1080. (Pubitemid 29531943)
54. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology. 1992;3:194-202.
55. Neuhouser ML, Wassertheil-Smoller S, Thomson C, et al. Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Arch Intern Med. 2009;169:294-304.
56. Collaborative Group of the Primary Prevention Project. Low dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Lancet 2001;357:89-95.
57. Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154-160. (Pubitemid 30051646)
58. Lonn E, Bosch J, Yusuf S, et al. HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293:1338-1347. (Pubitemid 40381486)
59. Salonen JT, Nyyssönen K, Salonen R, et al. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med. 2000;248:377-386.
60. Lee IM, Cook NR, Manson JE, et al. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst. 1999;91:2102-2106. (Pubitemid 30019571)
61. Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: theWomen's Health Study: a randomized controlled trial. JAMA. 2005;294:56-65. (Pubitemid 41002839)
62. GISSI-Prevenzione Investigators. Dietary supplements with n-3 poly unsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevention Trial. Lancet. 1999;354:447-455.
63. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145-1149. (Pubitemid 26137972)
64. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET: the Beta Carotene and Retinol Efficacy Trial. J Natl Canc Inst. 1996;88:1550-1559. (Pubitemid 26374508)
65. Stephens NG, Parsons A, Schofield PM, et al. Randomized, controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet. 1996;347:781-786. (Pubitemid 26091640)
66. ATBC (Alpha-Tocopherol, Beta Carotene) Cancer Prevention Study Group: the effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330: 1029-1035.
67. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease specific mortality in the general population. J Natl Cancer Ins. 1993;85:1483-1492. (Pubitemid 23269183)
68. Cook NR, Albert CM, Gaziano JM, et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med. 2007;167:1610-1618. (Pubitemid 47280341)
69. Albert CM, Cook NR, Gaziano JM, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008;299:2027-2036. (Pubitemid 351656584)
70. Lin J, Cook NR, Albert C, et al. Vitamins C and E and beta carotene supplementation and cancer risk: a Randomized Controlled Trial. J Natl Cancer Inst. 2009;101:14-23.
71. Sesso HD, Buring JE, Christen WG, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2008;300:2123-2133.
72. Belch J, MacCuish A, Campbell I, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ. 2008;337:a1840
73. Grodstein F, Kang JH, Glynn RJ, et al. A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch Intern Med. 2007;167:2184-2190. (Pubitemid 350106737)
74. Boothby LA, Doering PL. Vitamin C and vitamin E for Alzheimer's disease. Ann Pharmacother. 2005;39:2073-2080.
75. Isaac MG, Quinn R, Tabet N. Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev. 2008;(3):CD002854.
76. Coulter ID, Hardy ML, Morton SC, et al. Antioxidants vitamin C and vitamin E for the prevention and treatment of cancer. J Gen Intern Med. 2006;21:735-744. (Pubitemid 43973559)
77. Ristow M, Zarsea K, Oberbachc A, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA. 2009;106:8665-8670.
78. Fürst R, Zahler S, Vollmar AM. Dexamethasone-induced expression of endothelial mitogen-activated protein kinase phosphatase-1 involves activation of the transcription factors activator protein-1 and 3#,5#-cyclic adenosine 5#-monophosphate response element-binding protein and the generation of reactive oxygen species. Endocrinology. 2008;149:3635-3642. (Pubitemid 351919577)
79. Weigert C, Brodbeck K, Brosius FC 3rd, et al. Evidence for a novel TGF-beta1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters. Diabetes. 2003;52:527-535. (Pubitemid 36173213)
80. Herlein JA, Fink BD, O'Malley Y, et al. Superoxide and respiratory coupling in mitochondria of insulin-deficient diabetic rats. Endocrinology. 2009;150:46-55.